Test Bank:
$d
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
$d $d $d $d $d $d $d $d $
Edition, 2024
d $d
, Table of Contents $d $d
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ......................................... 3
$d $d $d $d $d $d $d $d
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................. 13
$d $d $d $d
Chapter4: Pharmacogenetics and Pharmacogenomics............................................................................... 25
$d $d $d
Chapter 5: Pharmacology Across the Life Span ...................................................................................... 30
$d $d $d $d $d $d
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................. 36
$d $d $d $d $d $d
Chapter 7: Drug Development and Approval........................................................................................... 45
$d $d $d $d $d
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
$d $d $d $d $d $d $d $d $d
Substance Prescribing Chapter 10: Antibiotic Stewardship ...................................................................... 51
$d $d $d $d $d
Chapter 11: Applied Calculations for Prescribing ................................................................................... 58
$d $d $d $d $d
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
$d $d $d $d $d $d $d $d $d
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapt
$d $d $d $d $d $d $d $d $d $d $d
er 14: Pharmacotherapy for Eye Conditions.............................................................................................. 67
$d $d $d $d $d
Chapter 15: Pharmacotherapy for Skin Conditions.................................................................................. 74
$d $d $d $d $d
Chapter 16: Pharmacotherapy for Neurologic Conditions ....................................................................... 81
$d $d $d $d $d
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................................................ 94
$d $d $d $d $d
Chapter 18: Pharmacotherapy for Respiratory Conditions .................................................................... 106
$d $d $d $d $d
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Sup
$d $d $d $d $d $d $d $d $d
port............................................................................................................................................................. 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................ 128
$d $d $d $d $d
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ..................... 133
$d $d $d $d $d $d $d $d $d
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions........................... 146
$d $d $d $d $d $d $d
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................. 158
$d $d $d $d $d $d $d
Chapter 24: Pharmacotherapy for Endocrine Disorders ........................................................................ 163
$d $d $d $d $d
Chapter 25: Pharmacotherapy for Hematologic Disorders .................................................................... 174
$d $d $d $d $d
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................ 190
$d $d $d $d $d $d $d $d
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions .............................................. 196
$d $d $d $d $d $d $d
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions .................................................... 211
$d $d $d $d $d $d $d
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................ 217
$d $d $d $d $d $d
Chapter 30: Antimicrobial Pharmacotherapy .......................................................................................... 224
$d $d $d
Chapter 31: Antiretroviral Pharmacotherapy........................................................................................... 235
$d $d $d
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neur
$d $d $d $d $d $d $d $d $d $d
ocognitive Conditions ................................................................................................................................ 247
$d
Chapter 33: Pharmacotherapy for Pain Management ............................................................................ 257
$d $d $d $d $d
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance.................................... 267
$d $d $d $d $d $d $d $d $d
Chapter 35: Over-the-Counter Medications ............................................................................................ 283
$d $d $d
Chapter 36: Pharmacotherapy for Obesity .............................................................................................. 291
$d $d $d $d
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
$d $d $d $d $d $d $d $d
MULTIPLE CHOICE $d
• What is the primary purpose of the nursing assessment?
$d $d $d $d $d $d $d $d
A. Identifying underlying pathologic conditions $d $d $d
B. Assisting the physician in identifying medical conditions
$d $d $d $d $d $d
C. Determining the patients mental status $d $d $d $d
D. Exploring patient responses to health problems $d $d $d $d $d
ANS: D $d
A nursing assessment is done to identify the patients response to health
$d $d $d $d $d $d $d $d $d $d $d $d
problems. During the nursing assessment phase, a comprehensive inform
$d $d $d $d $d $d $d $d
ation base is developed through a physical examination, nursing history,
$d $d $d $d $d $d $d $d $d $
medication history, and professional observation. Identifying underlying
d $d $d $d $d $d $d $
pathologic conditions and assisting the physician in identifying medical
d $d $d $d $d $d $d $d $d $d
conditions is not part of the nursing process. Determining the patients
$d $d $d $d $d $d $d $d $d $d $d
mental status is one part of the nursing assessment, but it is not the
$d $d $d $d $d $d $d $d $d $d $d $d $d $
primary purpose.
d $d
DIF: Cognitive Level: Comprehension
$d $d $d
REF: dm 36 OBJ: 1 | 3 TOP: Nursin
$d $d $d $d $d $d $d $d $d
g Process Step: Assessment
$d $d $d
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
$d $d $d $d $d $d $d $d
• What is the basis of the NANDA I taxonomy?
$d $d $d $d $d $d $d $ d
A. Functional health patterns $d $d
B. Human response patterns $d $d
C. Basic human needs $d $d
D. Pathophysiologic needs $d
ANS: B $d
The NANDA I taxonomy identifies human response patterns. Fu
$ d $ d $ d $ d $ d $ d $ d $d
nctional components of health patterns are limited to activity, fluid vol
$d $d $d $d $d $d $d $d $d $d
ume, nutrition, self care, and sensory perception. Basic human needs c
$d $d $d $d $d $d $d $d $d $d
omprise less than merely health patterns. Pathophysiologic needs are
$d $d $d $d $d $d $d $d $ d
not part of the scope of NANDA I.
$d $d $d $d $d $d $d
, DIF: Cognitive Level: Knowledge RE
$d $d $d $d
F: pp. 37-38 OBJ: 5 TOP:
$d $d $d $d $d
Nursing Process Step: Diagnosis
$d $d $d
MSC: NCLEX Client Needs Category: Physiological Integrity
$d $d $d $d $d $d
• Which task is included in the assessment step of the nursing process?
$d $d $d $d $d $d $d $d $d $d $d
A. Establishing patient goals/outcomes $d $d
B. Implementing the nursing care plan (NCP) $d $d $d $d $d
C. Measuring goal/outcome achievement $d $d
D. Collecting and communicating data $d $d $d
ANS: D $d
Data are collected and communicated in the assessment phase of the nur
$d $d $d $d $d $d $d $d $d $d $d
sing process. Establishing goals is the function of planning.
$d $d $d $d $d $d $d $d
Implementing the NCP is the function of implementation. Measuring out
$d $d $d $d $d $d $d $d $d
come achievement is the function of evaluation.
$d $d $d $d $d $d
DIF: Cognitive Level: Comprehensio
$d $d $d
n REF: dm 36 OBJ: 2 | 3 TOP: Nursi
$d $d $d $d $d $d $d $d $d
ng Process Step: Assessment
$d $d $d
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
$d $d $d $d $d $d $d $d
• Which statement regarding nursing diagnoses is accurate?
$d $d $d $d $d $d
a. Nursing diagnoses remain the same for as long as the disease is present.
$d $d $d $d $d $d $d $d $d $d $d $d
b. Nursing diagnoses are written to identify disease states.
$d $d $d $d $d $d $d
c. Nursing diagnoses describe patient problems that nurses treat.
$d $d $d $d $d $d $d
d. Nursing diagnoses identify causes related to illness.
$d $d $d $d $d $d
ANS: C $d
Diagnostic statements identify problems a nurse is independently able t
$d $d $d $d $d $d $d $d $d
o treat within the scope of professional practice. Nursing diagnoses var
$d $d $d $d $d $d $d $d $d $d
y with the changing condition of the patient. The response patterns are
$d $d $d $d $d $d $d $d $d $d $d $d
unique to the patient and are not disease specific. Nursing diagnoses de
$d $d $d $d $d $d $d $d $d $d $d
scribe the patients human response pattern.
$d $d $d $d $d
DIF: Cognitive Level: Comprehension
$d $d $d
$d
Advanced Pharmacology for Prescribers 1st Edition Luu Kayingo Latest
$d $d $d $d $d $d $d $d $
Edition, 2024
d $d
, Table of Contents $d $d
Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines ......................................... 3
$d $d $d $d $d $d $d $d
Chapter 2: Pharmacokinetics /Chapter3: Pharmacodynamics .................................................................. 13
$d $d $d $d
Chapter4: Pharmacogenetics and Pharmacogenomics............................................................................... 25
$d $d $d
Chapter 5: Pharmacology Across the Life Span ...................................................................................... 30
$d $d $d $d $d $d
Chapter 6: Drug-Therapy Prescribing in Special Populations ................................................................. 36
$d $d $d $d $d $d
Chapter 7: Drug Development and Approval........................................................................................... 45
$d $d $d $d $d
Chapter 8-Chapter 10: Foundations of Prescription Writing Chapter 9: ResponsibleControlled-
$d $d $d $d $d $d $d $d $d
Substance Prescribing Chapter 10: Antibiotic Stewardship ...................................................................... 51
$d $d $d $d $d
Chapter 11: Applied Calculations for Prescribing ................................................................................... 58
$d $d $d $d $d
Chapter 12-: Promoting Adherence With Pharmacotherapy II: System-Specific and Patient-
$d $d $d $d $d $d $d $d $d
Focused Prescribing Chapter 13: Pharmacotherapy for Ear, Nose, Mouth, andThroat Conditions /Chapt
$d $d $d $d $d $d $d $d $d $d $d
er 14: Pharmacotherapy for Eye Conditions.............................................................................................. 67
$d $d $d $d $d
Chapter 15: Pharmacotherapy for Skin Conditions.................................................................................. 74
$d $d $d $d $d
Chapter 16: Pharmacotherapy for Neurologic Conditions ....................................................................... 81
$d $d $d $d $d
Chapter 17: Pharmacotherapy for Cardiovascular Conditions ................................................................ 94
$d $d $d $d $d
Chapter 18: Pharmacotherapy for Respiratory Conditions .................................................................... 106
$d $d $d $d $d
Chapter 19: Pharmacotherapy for Gastrointestinal Conditions and Conditions RequiringNutritional Sup
$d $d $d $d $d $d $d $d $d
port............................................................................................................................................................. 117
Chapter 20: Pharmacotherapy for Genitourinary Conditions ................................................................ 128
$d $d $d $d $d
Chapter 21: Pharmacotherapy for Renal, Acid–Base, Fluid, and Electrolyte Disorders ..................... 133
$d $d $d $d $d $d $d $d $d
Chapter 22: Pharmacotherapy for Musculoskeletal and Rheumatologic Conditions........................... 146
$d $d $d $d $d $d $d
Chapter 23: Therapeutic Applications of Immunology and Vaccines ................................................. 158
$d $d $d $d $d $d $d
Chapter 24: Pharmacotherapy for Endocrine Disorders ........................................................................ 163
$d $d $d $d $d
Chapter 25: Pharmacotherapy for Hematologic Disorders .................................................................... 174
$d $d $d $d $d
Chapter 26: Hematology/Oncology and Supportive Care for the Nononcologist ................................ 190
$d $d $d $d $d $d $d $d
Chapter 27: Pharmacotherapy Related to Women’s Health Conditions .............................................. 196
$d $d $d $d $d $d $d
Chapter 28: Pharmacotherapy Related to Men’s Health Conditions .................................................... 211
$d $d $d $d $d $d $d
Chapter 29: Pharmacotherapy Related to Transgender Care ................................................................ 217
$d $d $d $d $d $d
Chapter 30: Antimicrobial Pharmacotherapy .......................................................................................... 224
$d $d $d
Chapter 31: Antiretroviral Pharmacotherapy........................................................................................... 235
$d $d $d
Chapter 32: Psychopharmacology and Integrative Health: Combined Treatment ofPsychiatric and Neur
$d $d $d $d $d $d $d $d $d $d
ocognitive Conditions ................................................................................................................................ 247
$d
Chapter 33: Pharmacotherapy for Pain Management ............................................................................ 257
$d $d $d $d $d
Chapter 34: Substance Use Disorder III: Health Promotion and Maintenance.................................... 267
$d $d $d $d $d $d $d $d $d
Chapter 35: Over-the-Counter Medications ............................................................................................ 283
$d $d $d
Chapter 36: Pharmacotherapy for Obesity .............................................................................................. 291
$d $d $d $d
,Chapter 1: An Introduction to Evidence-Based Clinical Practice Guidelines
$d $d $d $d $d $d $d $d
MULTIPLE CHOICE $d
• What is the primary purpose of the nursing assessment?
$d $d $d $d $d $d $d $d
A. Identifying underlying pathologic conditions $d $d $d
B. Assisting the physician in identifying medical conditions
$d $d $d $d $d $d
C. Determining the patients mental status $d $d $d $d
D. Exploring patient responses to health problems $d $d $d $d $d
ANS: D $d
A nursing assessment is done to identify the patients response to health
$d $d $d $d $d $d $d $d $d $d $d $d
problems. During the nursing assessment phase, a comprehensive inform
$d $d $d $d $d $d $d $d
ation base is developed through a physical examination, nursing history,
$d $d $d $d $d $d $d $d $d $
medication history, and professional observation. Identifying underlying
d $d $d $d $d $d $d $
pathologic conditions and assisting the physician in identifying medical
d $d $d $d $d $d $d $d $d $d
conditions is not part of the nursing process. Determining the patients
$d $d $d $d $d $d $d $d $d $d $d
mental status is one part of the nursing assessment, but it is not the
$d $d $d $d $d $d $d $d $d $d $d $d $d $
primary purpose.
d $d
DIF: Cognitive Level: Comprehension
$d $d $d
REF: dm 36 OBJ: 1 | 3 TOP: Nursin
$d $d $d $d $d $d $d $d $d
g Process Step: Assessment
$d $d $d
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
$d $d $d $d $d $d $d $d
• What is the basis of the NANDA I taxonomy?
$d $d $d $d $d $d $d $ d
A. Functional health patterns $d $d
B. Human response patterns $d $d
C. Basic human needs $d $d
D. Pathophysiologic needs $d
ANS: B $d
The NANDA I taxonomy identifies human response patterns. Fu
$ d $ d $ d $ d $ d $ d $ d $d
nctional components of health patterns are limited to activity, fluid vol
$d $d $d $d $d $d $d $d $d $d
ume, nutrition, self care, and sensory perception. Basic human needs c
$d $d $d $d $d $d $d $d $d $d
omprise less than merely health patterns. Pathophysiologic needs are
$d $d $d $d $d $d $d $d $ d
not part of the scope of NANDA I.
$d $d $d $d $d $d $d
, DIF: Cognitive Level: Knowledge RE
$d $d $d $d
F: pp. 37-38 OBJ: 5 TOP:
$d $d $d $d $d
Nursing Process Step: Diagnosis
$d $d $d
MSC: NCLEX Client Needs Category: Physiological Integrity
$d $d $d $d $d $d
• Which task is included in the assessment step of the nursing process?
$d $d $d $d $d $d $d $d $d $d $d
A. Establishing patient goals/outcomes $d $d
B. Implementing the nursing care plan (NCP) $d $d $d $d $d
C. Measuring goal/outcome achievement $d $d
D. Collecting and communicating data $d $d $d
ANS: D $d
Data are collected and communicated in the assessment phase of the nur
$d $d $d $d $d $d $d $d $d $d $d
sing process. Establishing goals is the function of planning.
$d $d $d $d $d $d $d $d
Implementing the NCP is the function of implementation. Measuring out
$d $d $d $d $d $d $d $d $d
come achievement is the function of evaluation.
$d $d $d $d $d $d
DIF: Cognitive Level: Comprehensio
$d $d $d
n REF: dm 36 OBJ: 2 | 3 TOP: Nursi
$d $d $d $d $d $d $d $d $d
ng Process Step: Assessment
$d $d $d
MSC: NCLEX Client Needs Category: Health Promotion and Maintenance
$d $d $d $d $d $d $d $d
• Which statement regarding nursing diagnoses is accurate?
$d $d $d $d $d $d
a. Nursing diagnoses remain the same for as long as the disease is present.
$d $d $d $d $d $d $d $d $d $d $d $d
b. Nursing diagnoses are written to identify disease states.
$d $d $d $d $d $d $d
c. Nursing diagnoses describe patient problems that nurses treat.
$d $d $d $d $d $d $d
d. Nursing diagnoses identify causes related to illness.
$d $d $d $d $d $d
ANS: C $d
Diagnostic statements identify problems a nurse is independently able t
$d $d $d $d $d $d $d $d $d
o treat within the scope of professional practice. Nursing diagnoses var
$d $d $d $d $d $d $d $d $d $d
y with the changing condition of the patient. The response patterns are
$d $d $d $d $d $d $d $d $d $d $d $d
unique to the patient and are not disease specific. Nursing diagnoses de
$d $d $d $d $d $d $d $d $d $d $d
scribe the patients human response pattern.
$d $d $d $d $d
DIF: Cognitive Level: Comprehension
$d $d $d
